Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hexagon's CEO sells shares — remains committed CEO and shareholder

Hexagon's President and CEO, Ola Rollén, has on 5 and 8 November 2021 sold a total of 1,506,225 shares in Hexagon AB. During 2020 and 2021, Ola Rollén obtained 318,195 share-based performance awards as part of two long-term incentive programmes with vesting periods of 2020/2023 and 2021/2024. Ola Rollén remains a committed CEO and shareholder in Hexagon, owning 502,075 shares and 318,195 share-based performance awards, corresponding to a total of approximately 117.2 MSEK based on the closing price on 9 November."I have decided to sell a portion of my private holding in Hexagon. I remain

Nordic Nanovector supports The Health Policy Partnership’s initiative to improve appropriate readiness for radioligand therapy (radioimmunotherapy) in lymphoma

Abstract by The Health Policy Partnership entitled “System-Level Barriers to Uptake of Existing and Novel Radioimmunotherapy for People with Lymphoma” will be presented at the 63[rd] ASH Annual Meeting, 11–14 December 2021Oslo, Norway, 9 November 2021 Nordic Nanovector ASA (OSE: NANOV) a clinical-stage biotechnology company dedicated to extending and improving the lives of patients with haematological cancers, is supporting an independent government affairs project led by The Health Policy Partnership (HPP), a specialist health policy research organisation. Within this project, an

Terveystalo Plc: SHARE REPURCHASE 9.11.2021

Terveystalo Plc ANNOUNCEMENT  9.11.2021 Terveystalo Plc: SHARE REPURCHASE 9.11.2021 In the Helsinki Stock Exchange Trade date           9.11.2021Bourse trade         BuyShare                  TTALOAmount             9 000 SharesAverage price/ share    11,2662 EURTotal cost            101 395,80 EUR Terveystalo Plc now holds a total of 856 634 sharesincluding the shares repurchased on 9.11.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

Solving the mysteries of Palermo’s child mummies

The first ever comprehensive study of mummified children in Sicily’s famous Capuchin Catacombs is being led by Staffordshire University.Dr Kirsty Squires, Associate Professor of Bioarchaeology, and her team have been given exclusive access to a previously unstudied collection of children’s mummies housed in the underground cemetery of the Capuchin Convent in Palermo. The Catacombs contain the largest collection of mummies in Europe, with over 1,284 mummified and skeletonised bodies dating from the late sixteenth to early twentieth century. Children were accepted in the Catacombs from

Arctic Paper S.A., Q3 2021: Strong demand and growing revenues

•     Q3 consolidated sales revenue was PLN 889.7mn (EUR1 195.6mn). •     EBITDA Q3 was PLN 102.1mn (EUR1 22.4mn). •     EBIT Q3 was PLN 72.8mn (EUR1 16.0mn) and net profit PLN 53.4mn (EUR1 11.7mn). •     Combination of pulp and paper continues to stabilise results as fluctuations offset each other. •     Strong quarter with paper production on record-high and the order books are full for the year. •     New group strategy for 2030 adding packaging & power using existing strengths. •     LOI signed with Rottneros to invest in sustainable fibre tray production in Kostrzyn.

The Board of Directors of Investment AB Latour (publ) has decided to exercise the authorization to repurchase shares

The Board of Directors of Investment AB Latour (publ) has decided, pursuant to the authorization granted by the Annual General Meeting held on May 10, 2021, to acquire own shares on Nasdaq Stockholm. The purpose of the acquisition is to ensure Latour's commitments to deliver shares in accordance with Latour's call option program. The repurchase may commence on November 10 2021 and will be administrated by Skandinaviska Enskilda Banken AB (publ), which will take trading decisions independently of Latour with regard to the timing of the acquisition. Share repurchases will be carried out

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.11.2021

United Bankers Corporation NOTIFICATION 09.11.2021 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 09.11.2021 Date 09.11.2021Exchange transaction BuyShare class UNITEDAmount 125Average price/share 13.7000 EURHighest price/share 13.7000 EURLowest price/share 13.7000 EURTotal price 1,712.50 EUR The shares held by United Bankers Corporation on 09.11.2021: UNITED 51,465 On behalf of United Bankers Corporation  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka

Photocure ASA: Invitation to presentation of third quarter 2021 financial results

Oslo, Norway, 9 November 2021: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2021 financial results on Wednesday 17 November 2021 at 07:30 CET and invites investors, analysts and the media to a presentation at 14:00 CET the same day.The investor presentation will be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event.The quarterly report and presentation will be published at 07:30 CET and will be publicly available at www.photocure.com. The streaming

Netherlands and Japan increased their market shares of globally traded wood pellets substantially in 2021

In 2020, wood pellet production in Europe was up 4% y-o-y and was 34% higher than in 2016, according to data just released by the UNECE. Despite this increase, production has not kept up with consumption, resulting in higher net imports to the continent over the past few years. To fill the supply deficit, Europe has imported almost 10 million tons of pellets annually from the US, Canada, and Russia in 2019 and 2020.   Overseas supply to Europe has been on an upward trajectory, doubling between 2013 to 2020. North America's pellet production rose from 6.5 million tons to 12.2 million

SpareBank 1 SR-Bank: Distribution of shares as part of the savings scheme for employees

The shares purchased by SpareBank 1 SR-Bank ASA 28 October and 29 October 2021 for use in the group's savings scheme for employees, have been distributed to the employees at a price of NOK 130,46893. After allocation the banks total holding of own shares is 41 225 shares. As participants in the savings scheme the primary insiders have acquired shares in accordance with the enclosed list.

Enersense International Plc: Flagging notification under chapter 9, section 10 of the Securities Markets Act

Enersense International PlcStock exchange release 9 November 2021 at 5:45 p.m.Enersense International Plc has received a notification under chapter 9, section 5 of the Securities Markets Act from Janne Vertanen. According to the notification, the shareholding of Janne Vertanen and entities controlled by him, in Enersense International Plc has exceeded 10% of all shares in Enersense International Plc on 8 November 2021. According to the notification, Janne Vertanen and entities controlled by him hold a total of 1,344,425 shares in Enersense International Plc, which corresponds to 10.035%

Alligator Bioscience publishes prospectus in connection with forthcoming rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.The Board of Directors of Alligator Bioscience AB (publ) ("Alligator" or the "Company") has prepared a prospectus (the "Prospectus") relating to the rights issue of shares of approximately SEK 257 million (the “Rights Issue"), which was resolved

Modus Therapeutics Receives Regulatory Approval to Start a Phase 1b Clinical LPS Challenge Study with Sevuparin in the Netherlands

STOCKHOLM, SWEDEN – 9 November 2021: Modus Therapeutics Holding AB (“Modus”), a company developing innovative treatments for patients with high unmet medical needs, announces that it has received the approval for its planned phase 1b clinical trial with sevuparin by the competent authorities in the Netherlands.The planned randomized, placebo-controlled Phase 1b study will evaluate the effects of intravenous sevuparin on the dermal and systemic lipopolysaccharide (LPS) induced inflammatory responses in healthy volunteers. The LPS challenge is a well-established model used to characterize the

My Singing Monsters Playground Released Today

EG7 today announces the release of My Singing Monsters Playground for PlayStation 5, PlayStation 4, Xbox Series X/S, Xbox One, Nintendo Switch and PC via Steam. Developed by Big Blue Bubble, My Singing Monsters Playground is an all-new party game set in the globally renowned and imaginative My Singing Monsters universe. My Singing Monsters Playground has players take control of their favorite Monsters and compete in tournaments of Monster-game madness. Set across locations throughout the world of My Singing Monsters, players will be able to explore and see the Monsters come to life

BerGenBio ASA: Increase of share capital, exercise of share options

Bergen, Norway, 9 November 2021 The Board of Directors in BerGenBio ASA (the"Company") (OSE: BGBIO) have, to fulfil the Company's obligations under the share option agreements and in accordance with the authorization granted by the general meeting on 19 March 2021, resolved to increase the Company's share capital by NOK 7,000 by issuance of 70,000 new shares. The new shares are subscribed for by option owners who wishes and are entitled to exercise options in accordance with the Company's option scheme. Each option gives a right to receive one share in the Company. The subscription price

Notice to Annual General Meeting in ODI Pharma AB (publ)

This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In case of any discrepancies between the Swedish original and this translation, the Swedish version shall prevail. The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Monday, 13[th] of December 2021, at 10.00 in the office of the company at Östermalmstorg 1, 114 42 Stockholm.Right to participate and registration Shareholders who wish to attend the Annual General Meeting shall · be included

#21-369 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-368 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

LEAX Group contemplates public listing in 2022

LEAX Group AB (“LEAX” or the “Company”) has previously communicated that the Board of Directors and the Company’s owners are assessing the possibilities for a listing of the Company’s shares. Today, LEAX can announce that the Company plans a public listing of the shares in the Company on Nasdaq Stockholm during the first half of 2022 and that the Company has appointed Danske Bank as financial advisor and Gernandt & Danielsson Advokatbyrå as legal advisor in connection with the listing.“We already have a listed bond, and a listing of our shares would be a logical next step in our expansion.

Storskogen publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

On 14 May 2021, Storskogen Group AB (publ) ("Storskogen") successfully issued senior unsecured bonds in an initial amount of SEK 3 billion, under a total framework of SEK 4 billion (the “Bonds”). The Bonds have a tenor of three years and a floating interest rate of STIBOR three months plus 300 bps.Pursuant to the terms and conditions for the Bonds, Storskogen has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus which today has been approved by the Swedish Financial

Nordnet issues Additional Tier 1 Capital

Nordnet issues Additional Tier 1 Capital to optimize its capital structure. The issuance amounts to SEK 600 million.The bond has a perpetual maturity with a first call option after five years. The interest rate is three months STIBOR + 3.90 percent. Settlement date is 16 November 2021. The bond will be listed at Nasdaq Stockholm. Nordea and SEB have acted as financial advisors in the transaction, and Mannheimer Swartling as legal advisor.

BioGaia AB’s Nomination Committee for the 2022 Annual General Meeting

BioGaia AB’s Nomination Committee for the Annual General Meeting 2022 has been appointed based on the ownership structure as of June 30, 2021. The Nomination Committee consists of: · Per-Erik Andersson, Annwall & Rothschild Investments AB · Fredrik Åtting, EQT · Marianne Flink, AP4 · Carlos Moreno, Premier Milton Investors and  · Peter Rothschild, Chair of the Board BioGaia AB  Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nominationcommittee@biogaia.com or by ordinary mail under the address BioGaia AB, Nomination

SubAir Systems and Soil Scout announce partnership to give groundskeepers unparalleled visibility and operational control of their turf

Soil Scout’s sensors detect the turf’s underground moisture, temperature, and salinity levels while SubAir Systems’ units automatically adjust the moisture levels to provide optimized conditions for turf managersUS-based SubAir Sports Systems  has announced a partnership with wireless underground soil moisture sensor startup Soil Scout  to give turf managers unprecedented control over their operations and turf with automated subsurface monitoring and ventilation.   Soil Scout’s sensor transmits moisture, temperature, and salinity

Sandvik announces first three members of the Board of SMT – the new company planned to be listed in 2022

As previously communicated, the Sandvik Board intends to formally propose the distribution and listing of its business area Sandvik Materials Technology (SMT) at a shareholders' meeting next year, with the target to complete the listing in the second or third quarter of 2022, subject to shareholder approval. The listing is planned to be made at the Nasdaq Stockholm Exchange. As part of this process, the Sandvik Board of Directors has appointed Andreas Nordbrandt as Chairman of the Board of SMT. Additionally, Claes Boustedt and Karl Åberg have been appointed as members of the SMT Board of

There are no items matching the current filter
There are no more items matching the current filter
Back to top